MedPath

A clinical study on efficacy of combination therapy of triptan agent and anti-epileptic drug in patients with severe migraine seizures

Not Applicable
Conditions
Migraine
Registration Number
JPRN-UMIN000029846
Lead Sponsor
Tokyo Women's Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
110
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria are: 1) Subjects diagnosed secondary headache 2) Subjects judged to be inappropriate as a study subject by the key investigator or sub-investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath